Metabolic Syndrome Clinical Trial
Non-alcoholic fatty liver disease (NAFLD) is now recognised as the hepatic complication of
the metabolic syndrome of insulin resistance. In some patients, the disease can progress
into steatohepatitis (NASH) which associates fatty liver, hepatocellular damage, chronic
inflammation and variable and progressive fibrosis. The latter can evolve into cirrhosis and
end-stage liver disease.
Thus the presence of fibrosis sign the severity of the disease, and therefore its accurate
detection is crucial for the identification of patients in need of treatment and appropriate
follow-up.
To date, histological examination of a biopsy of the liver is the gold standard in the
diagnosis of fibrosis. the procedure is however associated with significant complication in
0.01 to 0.1% of cases and with sampling errors because it analyses only a minimal portion fo
the liver.
The aim of the study is to evaluate, in a population of patients with the metabolic
syndrome, whether non-invasive tests may identify those with hepatic fibrosis.
At inclusion, serum tests, fibroscan (elastography of the liver by ultra-sounds) and
elastography by MRI will be performed. Those tests will be repeated within 2 months.
A liver biopsy will be performed if 2 out of the 3 (serum test, fibroscan or elastography)
tests are suggestive of hepatic fibrosis.
This study will allow to determine
- whether hepatic fibrosis may be detected by non-invasive means in patients with
NAFLD/NASH.
- whether there is a correlation between non-invase tests and liver biopsy for assessment
of fibrosis and it severity
- whether the presence of fatty liver interfere with the results of the fibroscan and the
elastography.
- whether there are metabolic factors associated with an increased risk of fibrosis in
this population.
n/a
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04635202 -
Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome
|
N/A | |
| Completed |
NCT04053686 -
An Intervention to Reduce Prolonged Sitting in Police Staff
|
N/A | |
| Completed |
NCT05343858 -
Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Recruiting |
NCT05040958 -
Carotid Atherosclerotic Plaque Load and Neck Circumference
|
||
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Completed |
NCT03289897 -
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan
|
N/A | |
| Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
| Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
| Active, not recruiting |
NCT03613740 -
Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
|
Phase 2 | |
| Completed |
NCT04498455 -
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
|
Phase 4 | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
| Completed |
NCT03697382 -
Effect of Daily Steps on Fat Metabolism
|
N/A | |
| Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
| Completed |
NCT04509206 -
Virtual Teaching Kitchen
|
N/A | |
| Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A |